STEPHANIE HART: Open Payments
NPI 1659692200 · POST FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,642 in 169 payments from 40 companies in 2025. Trend: 2023 $3,941 · 2024 $6,054 · 2025 $3,642
Food & beverage: $3,527Education: $115
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $321 |
| E.R. Squibb & Sons, L.L.C. | 11 | $258 |
| PFIZER INC. | 11 | $253 |
| Regeneron Healthcare Solutions, Inc. | 13 | $238 |
| Astellas Pharma US Inc | 5 | $228 |
| Janssen Biotech, Inc. | 7 | $193 |
| Incyte Corporation | 4 | $192 |
| Exelixis Inc. | 10 | $190 |
| ABBVIE INC. | 7 | $188 |
| Eisai Inc. | 7 | $143 |
Products named: Vyloy, JAKAFI, REBLOZYL, EPKINLY, RYBREVANT, Lenvima, LIBTAYO, SCEMBLIX.
Industry payments across ID — which companies pay providers there.
